Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 69Prostatic Neoplasms 47Breast Neoplasms 14Sarcoma 10Neoplasms 10Endometrial Neoplasms 9Vaginal Neoplasms 7Esophageal Neoplasms 6Uterine Neoplasms 4Radiation Injuries 4Lung Neoplasms 4Liver Neoplasms 4Glioblastoma 4Carcinoma, Ductal, Breast 4Adenocarcinoma 4Vulvar Neoplasms 3Neuroectodermal Tumors, Primitive, Peripheral 3Hyperthermia 3Gliosarcoma 3Desmoplastic Small Round Cell Tumor 3Central Nervous System Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Breast Carcinoma In Situ 3Brain Neoplasms 3Uveal Melanoma 2Rhabdomyosarcoma 2Retinoblastoma 2Rectal Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Neoplasms 2

Interventions

pembrolizumab 1X-Rays 1Taxes 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiation 1Platinum 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Congresses as Topic 1Cisplatin 1Carboplatin 1Brachytherapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Locally Advanced Cervical Adenocarcinoma × Brachytherapy × Clear all
NCT07061977 2026-06-05

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

National Cancer Institute (NCI)

Phase 3 Recruiting
336 enrolled
Gynecologic

Locally Advanced Cervical Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡